By Devika Patel
Knoxville, Tenn., Sept. 4 - Helix BioPharma Corp. announced it will raise C$13.58 million in a private placement of units.
The company will sell 6,625,000 units of one common share and one warrant at C$2.05 apiece. Each warrant will be exercisable at C$2.87 for three years.
Settlement is expected on Sept. 11.
Proceeds will be used for working capital.
Helix BioPharma is an Aurora, Ont., biopharmaceutical company developing products for the treatment of cancer and pre-cancerous conditions.
| Issuer: | Helix BioPharma Corp.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | C$13,581,250
|
| Units: | 6,625,000
|
| Price: | C$2.05
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Three years
|
| Warrant strike price: | C$2.87
|
| Pricing date: | Sept. 4
|
| Settlement date: | Sept. 11
|
| Stock symbol: | Toronto: HBP
|
| Stock price: | C$2.28 at close Sept. 3
|
| Market capitalization: | C$123 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
